If they are telling the masses (staff) then it can't be too much. If they told them either great / terrible news on the viability of the company, would they perhaps not be breaching continuous disclosure rules???
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%